NCIt definition : An orally active aminoglutethimide derivative with potential antineoplastic activity.
Rogletimide reversibly inhibits the activity of aromatase, a cytochrome P450 family
enzyme found in many tissues and the key enzyme in the oxidative aromatization process
of androgens to estrogens. In estrogen-dependent cancers, the inhibition of aromatase
by this agent leads to a reduction in the synthesis of estrogen, thereby inhibiting
estrogen-mediated signal transduction and consequently reducing tumor cell growth.
In addition, rogletimide also inhibits enzymes that catalyzing conversion of cholesterol
to corticosteroids.;
UNII : 14P4QR28QF;
InChIKey : QXKJWHWUDVQATH-UHFFFAOYSA-N;
CAS number : 92788-10-8; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 92788-10-8
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;